Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Neutralization of X4- and R5-tropic HIV-1 NL4-3 variants by HOCl-modified serum albumins.

Polzer S, van Yperen M, Kirst M, Schwalbe B, Schaal H, Schreiber M.

BMC Res Notes. 2010 Jun 2;3:155. doi: 10.1186/1756-0500-3-155.

2.

Antigenic and 3D structural characterization of soluble X4 and hybrid X4-R5 HIV-1 Env trimers.

Arnold P, Himmels P, Weiß S, Decker TM, Markl J, Gatterdam V, Tampé R, Bartholomäus P, Dietrich U, Dürr R.

Retrovirology. 2014 May 30;11:42. doi: 10.1186/1742-4690-11-42.

3.

HIV-1 dual/mixed tropic isolates show different genetic and phenotypic characteristics and response to maraviroc in vitro.

Svicher V, Balestra E, Cento V, Sarmati L, Dori L, Vandenbroucke I, D'Arrigo R, Buonomini AR, Van Marck H, Surdo M, Saccomandi P, Mostmans W, Aerssens J, Aquaro S, Stuyver LJ, Andreoni M, Ceccherini-Silberstein F, Perno CF.

Antiviral Res. 2011 Apr;90(1):42-53. doi: 10.1016/j.antiviral.2011.02.005. Epub 2011 Feb 22.

PMID:
21349294
4.
5.
6.
7.

Shift of clinical human immunodeficiency virus type 1 isolates from X4 to R5 and prevention of emergence of the syncytium-inducing phenotype by blockade of CXCR4.

Esté JA, Cabrera C, Blanco J, Gutierrez A, Bridger G, Henson G, Clotet B, Schols D, De Clercq E.

J Virol. 1999 Jul;73(7):5577-85.

8.

Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120.

Derdeyn CA, Decker JM, Sfakianos JN, Wu X, O'Brien WA, Ratner L, Kappes JC, Shaw GM, Hunter E.

J Virol. 2000 Sep;74(18):8358-67.

9.

Neutralization profiles of primary human immunodeficiency virus type 1 isolates in the context of coreceptor usage.

Cecilia D, KewalRamani VN, O'Leary J, Volsky B, Nyambi P, Burda S, Xu S, Littman DR, Zolla-Pazner S.

J Virol. 1998 Sep;72(9):6988-96.

10.

Role of the HIV type 1 glycoprotein 120 V3 loop in determining coreceptor usage.

Verrier F, Borman AM, Brand D, Girard M.

AIDS Res Hum Retroviruses. 1999 May 20;15(8):731-43.

PMID:
10357469
11.

Virucidal activity of the dendrimer microbicide SPL7013 against HIV-1.

Telwatte S, Moore K, Johnson A, Tyssen D, Sterjovski J, Aldunate M, Gorry PR, Ramsland PA, Lewis GR, Paull JR, Sonza S, Tachedjian G.

Antiviral Res. 2011 Jun;90(3):195-9. doi: 10.1016/j.antiviral.2011.03.186. Epub 2011 Apr 1.

12.

Complex determinants in human immunodeficiency virus type 1 envelope gp120 mediate CXCR4-dependent infection of macrophages.

Ghaffari G, Tuttle DL, Briggs D, Burkhardt BR, Bhatt D, Andiman WA, Sleasman JW, Goodenow MM.

J Virol. 2005 Nov;79(21):13250-61.

13.
14.

3-hydroxyphthalic anhydride-modified human serum albumin as a microbicide candidate against HIV type 1 entry by targeting both viral envelope glycoprotein gp120 and cellular receptor CD4.

Li M, Duan J, Qiu J, Yu F, Che X, Jiang S, Li L.

AIDS Res Hum Retroviruses. 2013 Nov;29(11):1455-64. doi: 10.1089/AID.2013.0043. Epub 2013 Jun 18.

15.

R5X4 viruses are evolutionary, functional, and antigenic intermediates in the pathway of a simian-human immunodeficiency virus coreceptor switch.

Tasca S, Ho SH, Cheng-Mayer C.

J Virol. 2008 Jul;82(14):7089-99. doi: 10.1128/JVI.00570-08. Epub 2008 May 14.

16.

V3 loop truncations in HIV-1 envelope impart resistance to coreceptor inhibitors and enhanced sensitivity to neutralizing antibodies.

Laakso MM, Lee FH, Haggarty B, Agrawal C, Nolan KM, Biscone M, Romano J, Jordan AP, Leslie GJ, Meissner EG, Su L, Hoxie JA, Doms RW.

PLoS Pathog. 2007 Aug 24;3(8):e117.

17.
18.

A low-molecular-weight entry inhibitor of both CCR5- and CXCR4-tropic strains of human immunodeficiency virus type 1 targets a novel site on gp41.

Murray EJ, Leaman DP, Pawa N, Perkins H, Pickford C, Perros M, Zwick MB, Butler SL.

J Virol. 2010 Jul;84(14):7288-99. doi: 10.1128/JVI.00535-10. Epub 2010 Apr 28.

19.

Characterization of a dual-tropic human immunodeficiency virus (HIV-1) strain derived from the prototypical X4 isolate HXBc2.

Xiang SH, Pacheco B, Bowder D, Yuan W, Sodroski J.

Virology. 2013 Mar 30;438(1):5-13. doi: 10.1016/j.virol.2013.01.002. Epub 2013 Jan 29.

20.

Purifying selection of CCR5-tropic human immunodeficiency virus type 1 variants in AIDS subjects that have developed syncytium-inducing, CXCR4-tropic viruses.

Fernàndez G, Llano A, Esgleas M, Clotet B, Esté JA, Martínez MA.

J Gen Virol. 2006 May;87(Pt 5):1285-94.

PMID:
16603531

Supplemental Content

Support Center